- Title
- Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: A Proof of Concept Phase 2a Cohort Study
- Creators
- Anita Kohli - LeidosRama Kapoor - LeidosZayani Sims - National Institutes of Health Clinical CenterAmy Nelson - University of Maryland, BaltimoreSreetha Sidharthan - National Institutes of Health Clinical CenterBrian Lam - University of Pittsburgh Medical CenterRachel Silk - LeidosColleen Kotb - LeidosChloe Gross - LeidosGebeyehu Teferi - University of Pittsburgh Medical CenterKate Sugarman - University of Pittsburgh Medical CenterPhillip S. Pang - Gilead SciencesAnu Osinusi - Gilead SciencesMichael A. Polis - National Institute of Allergy and Infectious DiseasesVinod Rustgi - University of Pittsburgh Medical CenterHenry Masur - National Institutes of Health Clinical CenterShyam Kottilil - University of Maryland, Baltimore
- Publication Details
- The Lancet infectious diseases, Vol.15(9), pp.1049-1054
- Identifiers
- 991005968942002656
- Academic Unit
- Internal Medicine
- Language
- English
- Resource Type
- Journal article
Journal article
Ledipasvir and Sofosbuvir for Hepatitis C Genotype 4: A Proof of Concept Phase 2a Cohort Study
The Lancet infectious diseases, Vol.15(9), pp.1049-1054
07/14/2015
PMCID: PMC4561573
PMID: 26187031
Metrics
3 Record Views